2.285USD+1.11%Mkt Cap: 18.88M USDP/E: —Last update: 2026-05-26
Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone repl…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap18.88M USD
Enterprise Value-6.43M USD
Revenue (TTM)2.00M USD
Gross Profit-6.61M USD
Net Income (TTM)-9.63M USD
Revenue/Share0.3450 USD
Last Price2.285 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.79
PEG—
EV/EBITDA0.53
EV/Revenue-3.21
P/S9.14
P/B0.94
EPS (TTM)-1.96
EPS (Forward)-1.24
52W Range
1.8104% of range12.37
52W High12.37 USD
52W Low1.810 USD
Profitability
Gross Margin-334.26%
Oper. Margin-3224.09%
EBITDA Margin0.00%
Profit Margin-487.06%
ROE-66.50%
ROA-56.61%
Growth
Revenue Growth27.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.76M USD
CapEx (TTM)—
FCF Margin-297.90%
FCF Yield-31.59%
Net Debt-24.73M USD
Net Debt/EBITDA2.05
Balance Sheet
Debt/Equity—
Current Ratio9.99
Quick Ratio9.87
Book Value/Sh2.351 USD
Cash/Share3.000 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:17
Split DateMay 12, 2023
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)6.000 USD
Target Range6.000 USD – 6.000 USD
# Analysts1
Ownership
Shares Out.8.24M
Float6.88M
Insiders4.51%
Institutions44.29%
Short Interest
Short Ratio0.2d
Short % Float2.21%
Short % Out.2.16%
Shares Short173.72K
Short (prev mo.)143.66K
Technical
SMA 503.883 (-41.2%)
SMA 2004.754 (-51.9%)
Beta0.50
S&P 52W Chg28.31%
Avg Vol (30d)181.65K
Avg Vol (10d)96.64K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—